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Self-Assembled Surfactant Cyclic Peptide Nanostructures as Stabilizing 
Agents 
Dindyal Mandal,a,†,* Rakesh K. Tiwari,a,b,‡ Amir Nasrolahi Shirazi,a,‡ Donghoon Oh,a Guofeng Ye,a 
Antara Banerjee,c Arpita Yadav,c Keykavous Paranga,b,* 
Received (in XXX, XXX) Xth XXXXXXXXX 20XX, Accepted Xth XXXXXXXXX 20XX 5 
DOI: 10.1039/b000000x 
A number of cyclic peptides, including [FR]4, [FK]4, [WR]4, [CR]4, [AK]4, and [WK]n (n = 3-5) 
containing L-amino acids were synthesized using solid-phase peptide synthesis. We hypothesized that an 
optimal balance of hydrophobicity and charge could generate self-assembled nanostructures in aqueous 
solution by intramolecular and/or intermolecular interactions. Among all the designed peptides, [WR]n (n 10 
= 3-5) generated self-assembled vesicle-like nanostructures at room temperature as shown by 
Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), and/or Dynamic light 
scattering (DLS). This class of peptides represents the first report of surfactant-like cyclic peptides that 
self-assemble into nanostructures. A plausible mechanistic insight of self-assembly of [WR]5 was 
investigated by molecular modeling studies. Modified [WR]5 analogues, such as [WMeR]5. [WR(Me)2]5, 15 
[WMeR(Me)2]5, and [WdR]5 exhibited different morphologies than [WR]5 as shown by TEM observations. 
[WR]5 exhibited significant stabilizing effect for generated silver nanoparticles and glyceraldehyde-3-
phosphate dehydrogenase activity. These studies established a new class of surfactant-like cyclic peptides 
that self-assembled into nanostructures and could have potential applications for stabilizing of silver 
nanoparticles and protein biomolecules. 20 
1. Introduction 
Well-defined nanostructures have drawn significant attention in 
the fields of biomedicine and biotechnology, material science, 
and nanotechnology.1,2 The formation of ordered structures is 
facilitated by different types of noncovalent interactions, 25 
including electrostatic, hydrogen bonding, hydrophobic, and 
aromatic stacking.3−5 In this context, self-assembly of peptides at 
nanoscale has emerged as a subject of considerable interest in 
recent years. Various types of peptide nanostructures have been 
reported with applications in diverse fields, such as antibacterial 30 
agents,6 neurological regeneration,7 and biosensors.8,9 Ghadiri et 
al.10
 
showed that cyclic D,L-peptides composed of alternating D- 
and L- amino acid residues can self-assemble into nanotubes by  
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forming antiparallel hydrogen bonds between homochiral amino 
acid residues of adjacent rings. 
 Peptides have attracted much attention as an alternative to 50 
traditional surfactants for studies of membrane proteins, because 
of their tendency to augment the formation of ordered 
supramolecular assemblies.11 There is an urgent need to develop 
more suitable surfactants that can provide natural alternatives for 
studying the membrane environment.Linear surfactant-like 55 
peptides bearing hydrophilic and hydrophobic residues have 
shown to act as membrane protein stabilizers.12 Moreover, it has 
been reported that these peptides can spontaneously undergo self-
assembly to form dynamic nanostructures in a pure solution, 
similar as other lipids and surfactants12. Compared to linear 60 
peptides, cyclic peptides have greater potential as stabilizing 
agents due to their enhanced chemical and enzymatic stability.13 
Microbial cyclic peptide surfactants have been previously 
reported in the literature.14,15 Random discovery by screening and 
challenges in production of these natural surfactants by synthetic 65 
or genetic engineering methods have hindered further 
development of these analogs. Thus, the applications of natural 
cyclic peptides as surfactants and protein stabilizers remain less 
explored. We hypothesized that self-assembled cyclic peptides 
with stabilizing and surfactant properties can be designed 70 
rationally. Herein, we report the discovery of nanosized 
surfactant-like L-cyclic peptides and their potential application as 
a new class of silver nanoparticle and biomolecule stabilizers. To 
the best of our knowledge, this class of peptides represents the 
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first report of surfactant-like cyclic peptides that self-assemble 
into nanostructures. Furthermore, this is the first application of 
any surfactant-like synthetic cyclic peptide as a stabilizer for 
silver nanoparticles and an enzyme. 
2. Results and Discussion 5 
2.1. Self-Assembly of Peptides 
A number of cyclic peptides, including [FR]4, [FK]4, [WR]4, 
[CR]4, [AK]4, and [WK]5 (Fig. 1) containing L-amino acids were 
synthesized using solid-phase peptide synthesis. These peptide 
sequences were selected to consist of alternating hydrophobic and 10 
positively charged residues or alternating neutral and positively 
charged residues as controls. We hypothesized that an optimal 
balance of hydrophobicity and charge could generate self-
assembled nanostructures in aqueous solution by intramolecular 
and/or intermolecular interactions. We have previously reported 15 
that among all the synthesized cyclic peptides, amphipathic L-
cyclic peptide containing tryptophan and arginine efficiently 
delivered cargoes intracellularly.16 
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Fig. 1. Chemical Structures of synthesized cyclic peptides (F = 
phenylalanine, R = arginine, K = lysine, W = tryptophan, C = cysteine, A 
= alanine). 
 All the cyclic peptides (2 mM) were dissolved in water and 
their structural morphologies were investigated using 25 
Transmission Electron Microscopy (TEM) after a few days. 
Among all the designed peptides, [WR]4 (Fig. 1) generated self-
assembled nanostructures after a specific incubation time at room 
temperature. Six cyclic peptides had the combination of 
positively-charged residues and other amino acids. The indole 30 
ring of tryptophan in [WR]4 appears to play crucial role in self-
assembly because of high hydrophobicity and generating 
potential hydrophobic interactions. Moreover, the guanidine 
group of arginine residues in [WR]4 could take part in hydrogen 
bonding interactions. Other 5 cyclic peptides did not have optimal 35 
combination of hydrophobic and positively-charged residues 
required for self-assembly process. 
 Initial conventional-TEM imaging of [WR]4 (2 mM aqueous 
solution) showed vesicle-like structures after 4 days (Fig. S1, 
Supplementary information). Larger particles were observed by 40 
using conventional TEM microscope after a prolonged 
incubation. 
 Further evidence for the aggregation of [WR]4 was observed in 
a concentration-dependent fluorescence study. At lower 
concentrations, the fluorescence intensity was proportionally 45 
increased (excitation 280 nm, emission 360 nm). However, the 
intensity remained constant at a higher concentration of 1 mM 
(Fig. S2). The results suggest that fluorescence-quenching occurs 
at the concentration that is sufficiently high enough for aggregate 
formation. Since the hydrophobicity of Trp is weak, this peptide 50 
self-assembly occurs at a high concentration (i.e. ≥1 mM) 
possibly through intermolecular hydrophobic interactions 
between Trp residues. 
 
Fig. 2. (a) and (b) FE-SEM image of self-assembled structure of [WR]5 (2 55 
mM) in water after 20 days; (c) CD spectra of [WR]n (100 µM) in water, 
where n = 3-5; (d) TEM images of self-assembly of [WR]5 (100 µM) in 
PBS after 48 h; (e) TEM images of [WR]5 (100 µM) in PBS after 12 days. 
 As a result of the unusual behavior of [WR]4, other derivatives 
in this class ([WR]3 and [WR]5 (Fig. 1)) were synthesized and 60 
evaluated to investigate whether the ring size has any effect in the 
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self-assembly process. Structural investigations of analogues of 
[WR]3 and [WR]5 were accomplished by TEM. Vesicle-like 
structures were formed for all compounds in this class. TEM of 
[WR]3 demonstrated small structure sizes of ~100 nm after 14 
days incubation. [WR]4 and [WR]5 exhibited larger structures (~ 5 
550 and 930 nm respectively) with much higher frequency (Fig. 
S1). 
 Systematic studies on the self-assembly behavior of [WR]5 
were carried out using different tools. Direct dissolution of the 
peptide in water did not reveal any specific structures after 24 h. 10 
TEM images showed the formation of a few micelle-like 
structures after 48 h. Nanovesicle structures with a diameter 
between 50 and 100 nm were clearly observed after 12 days (Fig. 
S4). The formation of vesicles was also confirmed by Scanning 
Electron Microscopy (SEM) after 20 days incubation (Fig. 2a,b). 15 
SEM results clearly show self-assembly by aggregation of small 
particles to the larger particles. 
 Zeta-potential measurement by dynamic light scattering (DLS) 
showed that self-assembled [WR]5 and [WR]4 had positive ζ 
potential values (+56.2 ± 7.62 mV) and (+31.4 ± 6.83 mV), 20 
respectively, which further demonstrate the formation of the 
positively charged surfaces by the guanidinium of R residues. 
 It is well known that the secondary structure of the peptides 
plays a critical role on the self-assembly pattern. Thus, circular 
dichroism (CD) was used to assess the secondary structure of 25 
these peptides. CD spectra of aqueous solution of the peptides 
[WR]n (n = 3-5, 100 µM) at 25 °C (Fig. 2c) revealed two negative 
bands at approximately 202-205 nm, 214-216 nm and a positive 
band around 229 nm. To estimate the secondary structure content, 
CD spectra were analyzed using an estimation program.17 The 30 
analysis showed that peptides [WR]n n = 3-5 to have 37.6-38.8% 
random and 31.6-35.7% sheet component with the remaining 
assigned to turn (12.4-12.5%) and helix (11.5-13.1%) (Table S1). 
The CD spectra of [WR]n (n = 3-5) displayed a distinct minimum 
of ellipticity around 202-205 nm, indicating that the peptides 35 
exist mostly in random coil states. The appearance of negative 
band around 214-216 nm and positive band at 229 nm is 
attributed to the strong exciton coupling produced by the 
aromatic chromophores of indoles tryptophan residues stacking 
against one another.18 In addition, all peptides showed the strong 40 
negative bands around 214-216 nm and positive band at around 
190, which are characteristic of the formation of distorted β-sheet 
structures. In general, the backbone-backbone intermolecular 
hydrogen bonding interactions proceed through parallel or 
antiparallel β-sheet like stacking arrangements in linear 45 
peptides.10b The results indicate that the self-assembly of these 
cyclic peptides is driven mostly by the hydrophobic force, 
hydrogen bonding by partial β-structures, and/or π-π stacking 
interactions between tryptophan residues. These data are 
consistent with those obtained with the previously reported cyclic 50 
peptides19 where the peptides did not show any specific 
secondary structure, and they self assembled into bilayer 
vesicular nanostructures. The CD spectra demonstrated a 
significant increase in spectral elipticity of [WR]5 compared to 
that of [WR]3 and [WR]4, suggesting stronger 55 
intramolecular/intermolecular interactions in this peptide. These 
data are consistent with TEM exhibiting high population of 
nanostructures formation by [WR]5. Considering these facts, 
[WR]5 was chosen as a model peptide for further self-assembly 
studies in detail. 60 
 Dynamic light scattering (DLS) was employed to identify the 
self-assembled structures in solution by determining the size 
distribution of structures. DLS results showed that the majority 
(80%) of nanostructures of [WR]5 (100 µM) were found in the 
size range of 150-250 nm after 14 days (Fig. S3, Supplementary 65 
Information). Furthermore, it was observed that the size of the 
vesicle structures became larger over time as confirmed by TEM 
and SEM studies. This can be attributed to the fusion or 
aggregation of two or more vesicles as observed in the SEM 
image (Fig. S4, Supporting Information). This pattern of 70 
aggregation resembled with traditional surfactants. 
 To get a better understanding of the impact of time on the 
aggregation process, the time-dependent studies by DLS were 
conducted for [WR]n (n = 3-5). The samples were prepared in 
water at the concentration of (1 mM) and the size distribution was 75 
evaluated on the first, third, and fourteenth day. The first day 
presents the immediate size of the formed nanoparticles after 
dissolving in water. Initially, the peptides will have interactions 
with water. Additionally, intramolecular interactions contribute to 
the size distribution at this stage. The intramolecular and water 80 
hydrogen bonding interactions are generated mainly by the 
appropriate functional groups, such as guanidine residues. 
Subsequently, the size of nanoparticles was compared after 3 
days. The self-assembly trend in a short period is mainly related 
to the initial intramolecular interactions of peptide functional 85 
groups followed by the intermolecular interactions. However, the 
size distribution was also investigated after a relatively longer 
period (14 days) to determine the behavior of nanoparticles after 
a prolonged incubation time. At a longer period, it is expected 
that intermolecular interactions are the dominant driving force of 90 
self-assembly. 
 As depicted in Fig. 3, the majority of [WR]5 nanoparticles 
were found in 319 ± 54 nm after 1 day. However, after 3 days, the 
self-assembly triggered, and [WR]5 nanoparticles showed larger 
particles (395 ± 53 nm). This trend was continued, and after 2 95 
weeks as [WR]5 nanoparticles were observed in 543 ± 41 nm, 
suggesting that time is a critical element for the size distribution 
of nanoparticles. Similar pattern was observed for [WR]4 
nanoparticles. The size of [WR]4 nanoparticles were found to be 
306 ± 102 nm, 424 ± 46 nm, 641 ± 175 nm at days 1, 3, and 14, 100 
respectively. However, [WR]3 displayed a completely different 
pattern. [WR]3 nanoparticles started increasing from day 1 (241 ± 
100 nm) to day 3 (352 ± 7 nm). However, the nanoparticles size 
was decreased to 216 ± 0.01 nm after 2 weeks. Several factors 
could be responsible for the collapsing of [WR]3 nanoparticles, 105 
such as nanoparticles instability in the long term due to the small 
ring size and insufficient intramolecular or intermolecular 
interactions due to the high strain in the cycle, or inappropriate 
orientation of amino acids in the structure of peptide for 
interactions. Smaller ring size in [WR]3 leads to more puckered 110 
and more cup like nonplanar structure of monomer which is less 
suited for self assemblage. The conformation of monomer 
dictates the differences in shapes of aggregated supramolecules. 
These results suggest that although time is a critical element in 
the size of nanoparticles, stability of the nanoparticles could 115 
affect the self-assembly process in the long period. 
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 These data demonstrated the effect of the ring size the 
nanoparticles size. At day 1, [WR]3, [WR]4, [WR]5 were found to 
be in 241 ± 100, 306 ± 102, and 319 ± 54 nm respectively. This 
part of result showed that the number of involved amino acids is 
an important element in the immediate size distribution of 5 
nanoparticles since [WR]5 led to a larger size of nanoparticles 
compared to that of [WR]3. However, [WR]4 nanoparticles were 
measured to be in the size of 424 ± 46 nm compared to the size of 
[WR]3 (424 ± 46 nm) and [WR]5 (395 ± 53 nm) after 3 days 
incubation, suggesting that the ring size with 8 amino acids is 10 
optimal for self-assembly. This trend was similar after 2 weeks as 
[WR]4 nanoparticles (641 ± 175 nm) showed distinctly larger 
nanoparticles than [WR]3 (215 ± 0.01 nm) and [WR]5 (543 ± 41 
nm). These results indicate that a [WR] cyclic peptide with eight 
amino acids has an optimal ring size for the maximal 15 
intermolecular and intramolecular interactions after 14 days. 
However, primary nanoparticles size at day 1 was found to be 
ring size dependent.  
 Additional characterization data were provided for these 
peptides, such as fluorescence spectroscopy (Fig. S17) and FTIR. 20 
Because of the highly sensitive indole chromophore in the 
structure of the tryptophan, this amino acid was used for its 
intrinsic fluorescence studies. Three cyclic peptides such as 
[WR]3, [WR]4, and [WR]5 (100 µM in H2O) were used for 
fluorescence studies. The data showed higher fluorescence 25 
intensity for peptide containing higher number of tryptophan 
residues [WR]5. 
 ATR-FTIR was used to further characterize the peptide amide 
bond in [WR]4. The spectrum of the dry powder of the peptide 
mixture revealed a two amide-I stretching at 1654 and 1640 cm-1. 30 
In general, antiparallel β-structures exhibit a principle β-sheet 
amide-I stretching vibration maximum at 1630–1640 cm-1 with a 
secondary absorption at a frequency normally 50–70 cm-1 higher. 
The absence of the secondary absorption shows that [WR]4 
adopts partially a parallel β-structure orientation. This result is 35 
consistent with stacking observed from the self-assembly 
simulations (Fig. 3). 
 
Fig. 3. DLS studies of [WR]n (n = 3-5) (1 mM) at days 1, 3, and 
14. 40 
 
 Furthermore, the effect of salts and pH was investigated in the 
self-assembly process. [WR]5 showed self-assembled structures 
in phosphate buffered saline (PBS, pH 7.0) (Fig. 2e). The 
aggregation was faster in PBS compared to an aqueous solution 45 
resulting in the formation of a larger size of vesicles (500-1000 
nm) after 12 days (Fig. 2f). This could be due to the presence of 
different salts that can facilitate the self-assembly. CD also 
revealed the development of additional positive band at 196 nm 
in PBS. The pattern of structures formation has a resemblance 50 
with surfactant-like linear peptides reported by Nagai et al.20 
Moreover, it is well known that NaCl favors surfactant 
aggregation.21 When PBS containing NaCl (167 mM) was 
examined in the self-assembly of this peptide, the aggregation of 
[WR]5 was accelerated. NaCl decreases the repulsive force 55 
among the charged head groups, resulting in enhancement of 
hydrophobic interactions between the peptides. However, in 
acidic medium (0.02 N HCl), some irregular structures were 
observed initially but longer incubation time led to degradation of 
the structures (Fig. S5, Supporting Information). 60 
 In order to assess the different self-assembly behavior of 
[WR]5 in water and PBS, turbidity measurements22 were carried 
out to determine vesicle formation at 350 nm. Difference in 
turbidity was clearly visible from the results. A sudden increase 
in the absorbance was observed above certain concentrations in 65 
both cases. Critical Aggregation Constant (CAC) values were 
determined from the intersection point obtained by extrapolating 
the lines. The CAC values for this peptide in water and PBS were 
found to be 0.9 mM and 0.45 mM, respectively (Fig. S6, 
Supporting Information), suggesting surfactant-like nature of the 70 
peptide in the presence of salts.  
 Fluorescence studies were performed for [WR]4 to show the 
aggregation of the peptide at concentrations above 1 mM (Fig. 
S2) consistent with the data described in Fig. S6 for [WR]5. The 
aggregation of [WR]4 was observed in a concentration-dependent 75 
fluorescence study. At lower concentrations, the fluorescence 
intensity was proportionally increased (excitation 280 nm, 
emission 360 nm). However, the intensity remained constant at a 
higher concentration of 1 mM (Fig. S2, Supplementary 
Information).  80 
 As shown above, the self-assembly was promoted in the 
presence of salts. Molecular modeling studies were used to gain 
better insights of nanostructure formation with [WR]5 in the 
presence of counterions. Initial coordinates for [WR]5 were 
obtained using GAUSSVIEW.23 Ab initio Hartree Fock 85 
molecular orbital calculations with complete geometry 
optimizations were performed with 6-31G24 basis set on 
monomer [WR]5 utilizing GAUSSIAN’03 software. Two 
conformations were obtained (Fig. S7, Supporting Information). 
The lowest energy conformation did not allow any intramolecular 90 
H-bonding. Higher energy conformation (25 kCal/mol) shows 
intramolecular H-bonding between cationic and neutral side 
chains. Side chains have to reorganize for efficient intramolecular 
H-bonding resulting in higher energy conformation. In the lowest 
energy conformation tryptophan side chains are disposed 95 
perpendicular to backbone. Higher energy conformation being 
more planar seems more suited for stacking. Stacking efficiency 
was explored utilizing supermolecule type intermolecular 
interaction calculations. Stacking efficiency = Estacked supermolecule – 
(Emonomer × no. of monomers + Ecounterion × no. of counterions). 100 
 [WR]5 is an amphiphilic peptide. Cationic side chains may 
facilitate counterion assisted self-assembly. First, interaction of 
cationic side chains with small fluoride ions was studied (Fig. S8, 
Supporting Information). Fluoride counterions assisted self-
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assembly propensity of [WR]5 system and resulted in nanotubular 
formation (Fig. S9, Supporting Information). Then interaction of 
trifluoroacetate ions (CF3COO-) with cationic side chain was 
calculated, and counterion-mediated stacking was explored. The 
data indicated that [WR]5 can undergo self-assembly 5 
spontaneously in the presence of trifluoroacetate counterions. 
Trifluoroacetate counterions are larger in size. Thus, nanotubular 
stacking was not preferred. Instead, the system presented spiral 
noncovalent association (Fig. 4), giving rise to nanostructure 
formation. Longer period of self-assembly simulation generated 10 
structures with larger size as observed in TEM and SEM 
experiments. We assume that intramolecular along with 
intermolecular interactions, such as hydrogen binding, π-π 
interactions, and counterion interactions work cooperatively 
during the self-assembly process of [WR]5. Intramolecular 15 
hydrogen bonding between W and R residues results in the high 
energy conformation which is suited for stacking hence it 
indirectly helps. Intermolecular interaction is purely electrostatic 
between cationic R residues and counteranions which may be 
basically any anion small enough to squeeze between monomers 20 
and interact efficiently. In [WR]5, self-assembly does not depend 
mainly on diffusion of the peptide, but certainly depends on 
diffusion of counterions. In the absence of any medium i.e. 
without any counterions, [WR]5 show only minimal aggregation 
as it is not thermodynamically favored. 25 
 We propose that the hydrophobic segments in the peptide 
initialize the supramolecular self-assembly and drive the peptide 
to form nanospherical water-filled structures. The positively 
charged portion of the peptide containing arginine residues 
orients to face the aqueous and counterion environment. 30 
Moreover, the hydrophobic residues stabilize the nanostructure as 
the particles become larger through inter- and intra-molecular 
hydrogen bonding. Additionally, the relatively weaker hydrogen 
bonded segments in the secondary structures facilitate the peptide 
to manage the assemblies at extremely lower concentrations (e.g. 35 
100 µM). As it is shown in Fig. 2c, increasing the hydrophobicity 
character by increasing the number of tryptophan residues from 3 
to 5 for [WR]5 induced the formation of completely different 
secondary structure as it is shown by CD. However, as it is 
exhibited in Fig. 3, the size distribution of [WR]5 is relatively 40 
smaller than that of [WR]4 after 14 days showing that other 
parameters are also involved in the self-assembly process.25  
 
 
Fig. 4. Self-assembled nanostructure formation of [WR]5 in the presence 45 
of CF3COO- ions. Stacking efficiency is given in kCal/mol. 
 Additional molecular modeling studies were then conducted in 
the presence of a 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) membrane bilayer using SPC water 
model. Membrane was set up by system builder module. Then 50 
water was added. Whole system was subjected to simulated 
annealing followed by molecular dynamics at room temp for 5 ns. 
When the side view is observed carefully, it does show two 
distinct surfaces. Results of 5 ns trajectory showed that [WR]5 
dimer aligned at oil (mimicked by membrane)-water interface 55 
with hydrophobic surface containing tryptophan residues towards 
the hydrophobic residues in membrane, suggesting surfactant 
property of the peptide (Fig. S10). The stability of system at the 
interface and low RMSD for all heavy atoms with time indicated 
successful simulation of mode of action for [WR]5 system as a 60 
biosurfactant or peptide surfactant (pepfactant). At oil-water 
interface mimicked by membrane-water interface in these 
simulations, this aggregated supramolecular form stays as such 
with hydrophobic groups towards membrane and hydrophilic 
towards water indicating the type of micellar formation 65 
 
-542.76 kCal/mol -1042.00 kCal/mol -1528.21 kCal/mol
-2524.98 kCal/mol
-6819.73 kCal/mol
~ 5.3nm - 5.9 nm
~ 10.6nm – 9.9 nm
Thickness ~ 26.02 nm
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Fig. 5. Synthesized [WR]5 analogues. 
 In general, the intrinsic properties of a peptide sequence 
including hydrophobicity, charge, secondary structure propensity, 
and sequence patterning are responsible for controlling the self-5 
assembly process.26,27 Thus, in order to investigate the effect of 
hydrophobicity and charge in the self-assembly process and to 
gain further mechanistic insight into the packing of self-assembly 
of [WR]
 
series, a class of cyclic peptide analogues of [WR]5 was 
designed rationally by using modified building blocks of arginine 10 
and tryptophan (Fig. 5), and their self-assembly pattern was 
investigated. 
 Modified [WR]5 analogues exhibited different morphologies 
depending on the hydrophobicity and charge of the amino acids 
in the structure of the peptides as shown by TEM observations. 15 
To investigate the effect of hydrophobicity of tryptophan in the 
self-assembly, a new building block N-methyl-L-tryptophan 
(WMe) was used as the hydrophobic residue in place of 
tryptophan. The resulting cyclic peptide [WMeR]5 showed 
nanotubular structures instead of spherical vesicles as evidenced 20 
by TEM (Fig. 6). Here, enhanced hydrophobicity of the peptide 
and the absence of NH moiety of tryptophan played critical roles 
in the self-assembly process. 
 
Fig. 6. TEM images of self-assembled structures of [WMeR]5 (2 mM in 25 
water) after (A) 6 days and (B) 12 days. Individual nanotube structure is 
shown in inset (scale: 100 nm). 
 To determine the role of positively-charged arginine in the 
self-assembly process, another analogue [WR(Me)2]5 was 
synthesized by replacing the arginine with N,N-dimethylarginine 30 
keeping tryptophan as a hydrophobic residue unchanged. Thus, 
the hydrophilicity of the charged residues was reduced that 
resulted in poor water solubility. Unlike the previous peptides, 
this compound (1 mM aqueous solution) generated micelle-like 
spherical nanostructures (Fig. S11, Supporting Information). It 35 
was found that the compound did not exhibit any large vesicles 
like [WR]5 even after prolonged incubation (25 days), presumably 
due to the absence of one of free amine groups of guanidine. 
These data suggest that this free amino group contributes to the 
self-assembly process of [WR]5 possibly through hydrogen 40 
bonding. On the other hand, a peptide containing both N-
methyltryptophan (WMe) and N,N-dimethylarginine (R(Me)2) 
([WMeR(Me)2]5) did not produce any specific structures at 2 mM or 
4 mM concentration. At higher concentration (4 mM), 
[WMeR(Me)2]5 exhibited a few micelle-like nanostructures along 45 
with patches of membrane-like sheets between the nanostructures 
and copper grid during sample preparation (Fig. S12, Supporting 
Information). This peptide might have undergone self-assembly 
on the surface of copper grid by hydrophobic interactions to form 
monolayer membranes, possibly due to the highly hydrophobic 50 
nature of the amino acids. 
 The formation of nanotubes through the self-assembly of D,L-
cyclic peptides has been previously reported.10 The backbone-
backbone interactions between peptides were found to be critical 
for the self-assembly of D,L-cyclic peptides. Our results indicated 55 
that hydrophobicity and the charge were crucial for the self-
assembled structure formation for these cyclic peptides, as they 
were in the mechanism of linear surfactant-like peptides.11 Thus, 
we compared the nanostructure formation between homochiral 
[WR]5 with the corresponding heterochiral to evaluate the effect 60 
of stereochemistry. Thus, D,L-cyclic peptide [WdR]5, where dR 
is d-arginine, was designed and synthesized for the comparative 
stereochemistry studies. Unlike the nanotube formation by D,L-
cyclic peptides, [WdR]5 exhibited micelle like nanostructures 
after prolonged incubation at room temperature (Fig. S13, 65 
Supporting Information). The detailed mechanism of the self-
assembly for these cyclic peptides requires further investigation 
with modeling and simulation experiments. 
 Qualitative analysis of the conformation of these peptide 
analogues was obtained by CD. CD spectra of aqueous solution 70 
of the peptides [WMeR]5 and [WR(Me)2]5 at room temperature (Fig. 
S14, Supporting Information) revealed two negative bands at 
approximately 203 and 217 nm. This does not resemble either a 
classic β-sheet or α-helical structures. Another analogue 
[WMeR(Me)2]5 also showed similar bands, but with a lower 75 
elipticity. These three peptide analogues, namely [WMeR]5, 
[WR(Me)2]5 and [WMeR(Me)2]5, showed negative band at around 
217 nm and positive band at around 229 nm, which are 
characteristics of exciton coupling of tryptophan residues, 
indicating the presence of stacking interactions. However, 80 
[WdR]5 did not exhibit any characteristic signatures of exciton 
coupling of tryptophan side chain, suggesting the absence of 
stacking of indole rings. 
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2.2. Stabilization of Silver Nanoparticles by [WR]5 
and Modified Analogues 
We have previously reported the application of [WR]5 as a 
nuclear targeting molecular transporter for a wide range of 
cargos.16 It was found out that a physical mixture of [WR]5 and 5 
HAuCl4 led to the formation of peptide-capped gold nanoparticles 
and enhanced the cellular uptake of drugs significantly.28 We 
investigated to determine whether [WR]5 can be used for the 
stabilization of silver nanoparticles and proteins. Several methods 
for the synthesis of silver nanoparticles have been previously 10 
reported. However, the stabilization of silver nanoparticles is 
required for various applications. The stabilizing agents (e.g., 
surfactants, polymer) prevent the particle aggregation by 
protecting these particles by steric stabilization. Cationic 
surfactants are commonly used as stabilizing agents in silver 15 
nanoparticles synthesis.29 Accounting the above facts, we 
postulated that [WR]5 could behave as a cationic surfactant. 
 In order to explore whether [WR]5 can mimic the role of 
cationic surfactants in the synthesis of nanoparticles, a model 
experiment was performed using silver nitrate (AgNO3) as a 20 
source of Ag+ ion and sodium borohydride (NaBH4) as a reducing 
agent in the presence and absence of the cyclic peptide. Sodium 
borohydride was added into the equal volume mixture of cyclic 
peptide [WR]5 (1 mM) and AgNO3 (2 mM) solution. To 
demonstrate the role of cyclic peptide as stabilizer, sodium 25 
borohydride was used in excess amount (8 mM). The resulting 
mixture produced yellow color immediately, indicating the 
formation of silver nanoparticles. UV-Vis spectra showed the 
characteristic plasmon band of silver nanoparticles formation 
with a band at 410 nm (Fig. 7A). The formation of spherical 30 
silver nanoparticles was confirmed by TEM (Fig. 7B). In order to 
monitor the stability of the silver colloid, absorption of the 
colloid was measured after four weeks. The evolution of UV-Vis 
spectra is shown in Fig. 7A (curve b). There was only a minor red 
shift in peak position even after four weeks (curve c), confirming 35 
the stability of the silver colloids. No extra peaks or shoulders 
were developed even after one month, eliminating the possibility 
of aggregation. On the contrary, when sodium borohydride was 
added to AgNO3 (2 mM) solution in the absence of the peptide 
(Fig. 7A, curve a), stable silver nanoparticles were not formed. 40 
These data confirm the surfactant-like nature of the cyclic peptide 
[WR]5. The stability of silver nanoparticles was also examined in 
the presence of the corresponding linear peptide. The linear 
peptide was not efficient in stabilizing silver nanoparticles (Fig. 
S18). 45 
 The stabilization of silver nanoparticles with [WR]5 was 
compared with a traditional surfactant (cetyltrimethylammonium 
bromide, CTAB). CTAB is a well known cationic surfactant 
which is used as a stabilizer in nanoparticle synthesis. It is 
already reported in the literature that CTAB shows better 50 
stabilizing effect at low concentration.30 The stability of silver 
nanoparticles in the presence of CTAB was checked after 4 days, 
and it showed aggregation of nanoparticles. The decrease in band 
(~410 nm) intensity and development of extra band 
approximately at 610 nm indicate particle aggregation (Fig. S19). 55 
Traditional surfactant or some polymeric compounds form 
micelles which are used to stabilize the metal nanoparticles.31,32 
The micelles are porous cluster with deep water filled cavities. In 
case of traditional surfactants, micelles control the shape of the 
nanoparticles by trapping the metal ion and reagent in the small 60 
cavities. Here, micelles formed by peptides, are water rich. Due 
to self-assembly process, cyclic peptides initially form micelles 
which stabilize the nanoparticles. Thus, when AgNO3 and peptide 
solution are mixed, Ag+ ions may reside into the micelles. Once 
NaBH4 is added, Ag+ ions are converted into Ag0 that remains 65 
stable without any aggregation. Small surfactant-like peptides 
surround the metal nanoparticles and protect them from 
aggregation. TEM images shows clear layer of the peptide on 
nanoparticle surface (Fig. S20). This follows the similar model 
shown by a traditional surfactant. 70 
 
Fig. 7. (A) UV-Vis spectra of yellow color silver nanoparticles solution in 
the absence (a) and presence (b, c) of [WR]5 peptide and comparison of 
the stability of silver nanoparticles in the presence of peptide after 30 min 
reaction (curve b) and one month (curve c); (B) TEM image of silver 75 
nanoparticles synthesized by sodium borohydride in the presence of 
[WR]5. 
 The effect of the peptide concentration in stabilizing silver 
nanoparticles was investigated by using different concentrations 
of peptide. Visual observation showed that the typical color of 80 
silver nanoparticles changed from pale yellow to dark yellow and 
brown, respectively, indicating the alteration of nanoparticle 
morphology in the presence of different concentrations of 
peptide. This observation was consistent with UV-Vis 
spectroscopy (Fig. S15, Supporting Information) that showed a 85 
narrow band at 401 nm when 100 µM of the peptide was used. As 
the concentration of the peptide was increased from 100 to 200 
µM, the absorbance curve did not change significantly. However, 
the absorbance band became short and shifted towards longer 
wavelength when a peptide concentration of 500 µM was 90 
employed, indicating the aggregation and formation of larger 
particles. The absorbance band became broad and significantly 
shorter at the peptide concentration of 1 mM. The broadening of 
the band suggests wide distribution (higher dispersity) of particles 
size. These results revealed that the optimization of the peptide 95 
concentration is necessary to achieve narrower particle size 
distribution. This pattern is similar to other synthesized 
surfactant-stabilized silver nanoparticles. 
 To investigate whether the other synthesized cyclic peptide 
analogues can show surfactant-like properties, they were explored 100 
as stabilizing agents in the silver nanoparticles synthesis. Among 
them, [WMeR]5 showed a great potential as a stabilizing agent. 
Although it shows slight red shift (6 nm) in the band after one 
week, but there is no sign of aggregation of silver nanoparticles 
(Fig. 8A). This result supports the surfactant-like nature of 105 
[WMeR]5. However, the intensity of absorbance was decreased in 
the presence of [WR(Me)2]5 after 7 days (Fig. 8B), indicating the 
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aggregation of nanoparticles. Furthermore, in the presence of 
[WMeR(Me)2]5, the plasmon band of silver nanoparticles shifted (46 
nm) significantly to longer wavelength indicating the formation 
of large particles (Fig. 8C). Similar results were obtained for 
[WdR]5 (Fig. 8D). This could be attributed to the irregular 5 
structure formation by these peptides. 
 
Fig. 8. UV-vis spectra of silver nanoparticles in the presence of (A) 
[WMeR]5, (B) [WR(Me)2]5, (C) [WMeR(Me)2]5, and (D) [WdR]5 at room 
temperature after 15 min (a) and 7 days (b). 10 
2.3. Stabilization of Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH) by [WR]5 
It is already known that surfactants influence the enzymatic 
activities depending upon the interaction with the surface of the 
enzymes.33 Thus, the capability of this surfactant-like peptide in 15 
stabilizing biomacromolecules was investigated using 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a 
model enzyme. The activity of GAPDH enzyme was determined 
by using KDalert GAPDH assay kit. The KDalert GAPDH assay 
determines the conversion of NAD+ to NADH by GAPDH in the 20 
presence of phosphate and glyceraldehyde-3-phosphate (G-3-P). 
Under the suggested assay conditions, the rate of NADH 
production is proportional to the amount of GAPDH enzyme 
present. To evaluate the effectiveness of the peptide in stabilizing 
enzymatic activity, experiments were carried out by mixing the 25 
enzyme with various peptide concentrations in phosphate 
buffered saline (PBS, NaCl (167 mM), pH 7.0). GAPDH was 
mixed in PBS as a control. The activity of the enzyme at different 
time intervals in the presence and absence of the peptide was 
measured using the fluorescence-based method. Plots were made 30 
to show the increase in fluorescence due to NAD+ reduction vs 
time. It was observed that enzyme containing 100 µM of [WR]5 
showed significantly enhanced activity compared to the control 
enzyme (Fig. 9A), suggesting surfactant-like nature of the 
peptide. Moreover, the enzyme activity was reduced at higher 35 
peptide concentration (500 µM), presumably due to the 
denaturation of the enzyme, indicating the ionic nature of the 
peptide-surfactant. A control experiment was also performed 
without the enzyme to rule out any effect of the peptide in the 
reduction process. Negligible fluorescence was recorded when 40 
the peptide solution was mixed with other components in the 
absence of the enzyme. 
 
Fig. 9. Enzymatic activity of GAPDH. Changes in fluorescence due to 
NAD+  reduction are the result of GAPDH activity. (A) Enzymatic 45 
activity shown till 30 min at room temperature; (B) Enzymatic activity 
shown till 60 min at 50 ⁰C. (●) GAPDH enzyme in PBS, (■) GAPDH 
enzyme in PBS in the presence of [WR]5 (100 µM), (▲) GAPDH enzyme 
in PBS in the presence of [WR]5 (500 µM). 
 The presence of peptide-surfactant enhanced the activity of the 50 
enzyme as described. Thus, it was essential to verify the influence 
of the peptide on the stability of the enzyme. To this notion, the 
activity of GAPDH was determined in the presence of the peptide 
at 37 ⁰C and 50 ⁰C. The enzyme in the presence of the peptide 
showed 2-fold enhanced activity compared to control one at 50 55 
⁰C (Fig. 9B) and 37 ⁰C (Fig. S16, Supporting Information), 
indicating enhanced stability of GAPDH enzyme in the presence 
of the peptide-surfactant. These results suggest that this surfactant 
peptide could be a promising additive for stabilizing other 
biomacromolecules, such as membrane proteins. 60 
3. Experimental 
3.1. Synthesis of Cyclic Peptides 
The synthesis of cyclic peptides was carried out according to the 
previously reported procedure by us.16 All reactions were carried 
out in Bio-Rad polypropylene columns by shaking and mixing 65 
using a Glass-Col small tube rotator in dry conditions at room 
temperature unless otherwise stated. In general, all linear peptides 
were synthesized by the solid-phase synthesis strategy employing 
N-(9-fluorenyl)methoxycarbonyl (Fmoc)-based chemistry and 
Fmoc-L-amino acid building blocks. 2-(1H−Benzotriazole-1-yl)-70 
1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) and 
N,N-diisopropylethylamine (DIPEA) in N,N-dimethylformamide 
(DMF) were used as coupling and activating reagents, 
respectively. Fmoc-amino acid trityl chloride resins, 2-
chlorotrityl chloride resin, coupling reagents, and Fmoc-amino 75 
acid building blocks were purchased from Chempep (Miami, FL). 
Other chemicals and reagents were purchased from Sigma-
Aldrich Chemical Co. (Milwaukee, WI). Fmoc deprotection at 
each step was carried out using piperidine in DMF (20% v/v). 
Side chain protected peptides were cleaved from the resins by 80 
shaking the resins with a mixture of trifluoroethanol (TFE)/acetic 
acid/dichloromethane (DCM) (2:2:6, v/v/v, 15 mL) for 2 h. The 
resins were filtered off, and the liquid was evaporated to dryness 
to get side-chain protected linear peptide. The cyclization of the 
peptides was carried out in the presence of a mixture of 1-85 
hydroxy-7-azabenzotriazole (HOAt, 163.3 mg, 1.2 mmol) and 
N,N′-diisopropylcarbodiimide (DIC, 187 µL, 1.2 mmol) in dry 
DMF (100 mL), and dry DCM (40 mL) for 24 h. DMF and DCM 
were evaporated. The side chain deprotection was carried with 
trifluoroacetic acid (TFA)/thioanisole/anisole/1,2-ethanedithiol 90 
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(EDT) (90:5:2:3 v/v/v/v) for 2 h. The crude peptides were 
precipitated by the addition of cold diethyl ether (75 mL, Et2O) 
and purified by reversed-phase Hitachi HPLC (L-2455) on a 
Phenomenex Prodigy 10 µm ODS reversed-phase column (2.1 cm 
× 25 cm) with using a gradient system. The peptides were 5 
separated by eluting the crude peptides at 10.0 mL/min using a 
gradient of 0-100% acetonitrile (0.1% TFA) and water (0.1% 
TFA) over 60 min, and then, they were lyophilized. The chemical 
structure of [WR]4 was characterized by nuclear magnetic 
resonance spectra (1H NMR) determined on a Varian NMR 10 
spectrometer (500 MHz) as described previously.16 The chemical 
structures of all final products were confirmed by a high-
resolution Biosystems QStar Elite time-of-flight electrospray 
mass spectrometer. The purity of final products (>95%) was 
confirmed by analytical HPLC. The analytical HPLC was 15 
performed on the Hitachi analytical HPLC system on a C18 
Shimadzu Premier 3 µm column (150 cm × 4.6 mm). 
3.2. Synthesis of Fmoc-Trp(Me)-OH 
N-(9-Fluorenylmethoxycarbonyloxy)succinimide (Fmoc-ONSu, 
11.55 g, 0.034 mol) was added to a round bottom flask, dissolved 20 
with 75 mL of DMF with constant stirring at 0 °C. 1-Methyl-L-
trypthophan (5 g, 0.22 mol) was added to sodium carbonate 
solution (10%, 75 mL), and the mixture was stirred at room 
temperature to form a suspension. The suspension prepared above 
was added dropwise at 0 °C with constant stirring to the solution 25 
of Fmoc-ONSu in DMF. The precipitate formed immediately. 
The mixture was stirred for another 1 h and made at room 
temperature. Acetone (80 mL) was added to the mixture and the 
stirring continued overnight. The precipitate was removed by 
filtration, and the pH of the filtrate was adjusted to 7.0 with HCl. 30 
The solution was concentrated in a rotary evaporator. A 200 mL 
of ethyl acetate was added to the mixture and resulted solution 
was stirred for 6 h at room temperature. Ethyl acetate layer was 
washed with 100 mL of 0.1N HCl two times and then with brine 
(75 mL), and dried over anhydrous MgSO4 The solvent was 35 
removed with rotary evaporator to yield crude creamy solid 
compounds. The compound was re-crystallized in ethyl acetate to 
afford 4 g of pure material, which was used without further 
purification for the synthesis of cyclic peptides [WMeR]5, 
[WR(Me)2]5, and [WMeR(Me)2]5 according to the previously reported 40 
procedure.16 
 
[FK]4: HR-MS (ESI-TOF, m/z): [M]+ calcd for C60H84N12O8, 
1100.6535; found, 1100.5836 [M]+, 551.2918 [M + 2H]2+, 
367.8752 [M + 3H]3+.  45 
[AK]4: HR-MS (ESI-TOF, m/z): [M]+ calcd for C36H68N12O8, 
796.5283; found, 796.4868 [M]+, 399.2434 [M + 2H]2+. 
[CR]4: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C36H69N20O8S4, 1037.4490; found, 1037.4096 [M + H]+, 
345.1323 [M + 3H]3+, 259.1024 [M + 4H]4+. 50 
[FR]4: HR-MS (ESI-TOF) (m/z): [M]+ calcd for C60H84N20O8, 
1212.6781; found, 1212.6052 [M]+, 607.3026 [M + 2H]2+, 
405.5428 [M + 3H]2+, 304.1588 [M + 4H]3+. 
[WR]3: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C51H67N18O6, 1027.5491; found, 1027.6030 [M + H]+. 55 
[WR]4: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C68H89N24O8, 1369.7295; found, 1369.7934 [M + H]+, 685.3967 
[M + 2H]2+, 457.2696 [M + 3H]3+, 343.2066 [M + 4H]4+; FT-IR 
of [WR]4 was carried out using Thermo-Nicolet 380 FT-IR 
spectrophotometer using OMNIC software. FT IR (cm-1) (ATR): 60 
1654, 1640.36, 1531.22, 1494.39, 1431.63, 1198.35, 1170.79, 
1119.02, 837.31, 799.83, 745.55, 719.71. 
[WR]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C85H111N30O10, 1711.9099; found, 1711.6974 [M + H]+, 571.5658 
[M + 3H]3+, 428.9286 [M + 4H]4+, 343.1493 [M + 5H]5+. 65 
[WMeR]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C90H121N30O10, 1781.9882; found, 1782.0165 [M + H]+, 594.6633 
[M + 3H]3+, 446.4739 [M + 4H]4+, 357.4033 [M + 5H]5+. 
[WR(Me)2]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C95H131N30O10, 1852.0664; found, 1852.1065 [M + H]+, [M + 70 
2H]2+, 618.3545 [M + 3H]3+, 463.9962 [M + 4H]4+, 371.4213 [M 
+ 5H]5+. 
[WMeR(Me)2]5: HR-MS (ESI-TOF) (m/z): [M + H]+ calcd for 
C100H141N30O10, 1922.1447; found, 1921.5000 [M + H]+, 
483.9131 [M + 4H]4+, 383.6360 [M + 5H]5+. 75 
[WdR]5: HR-MS (ESI-TOF) (m/z): [M]+ calcd for 
C85H110N30O10, 1710.9021; found, 571.6383 [M + 3H]3+, 
428.9571 [M + 4H]4+, 343.3879 [M + 5H]5+. 
3.3. Transmission Electron Microscopy (TEM) 
3.3.1. Conventional TEM 80 
TEM sample was prepared by drop casting a 2 mM aqueous 
solution (10 µL) onto the formvar coated carbon grid of mesh 
size 300, which was allowed to sit for 2 min. Excess solvent was 
carefully removed by capillary action (filter paper). Grids were 
allowed to dry at room temperature for overnight and images 85 
were taken using JEOL Transmission Electron Microscope 
(Tokyo, Japan) maintained at 80 kv. 
3.3.2. Negative Staining 
After drop casting of peptide solution, grids were then stained 
with uranyl acetate (20 µL) for 2 min. Excess stain was removed, 90 
and the grids were allowed to dry for overnight. Images were 
taken using JEOL Transmission Electron Microscope (Tokyo, 
Japan) maintained at 80 kv. 
3.4. Scanning Electron Microscopy (SEM) 
SEM sample was prepared by drop casting a 2 mM aqueous 95 
solution (10 µL) onto the mica surface. Mica surface was allowed 
to dry at room temperature for overnight and analyzed in a Nova 
NanoSEM 450 using the Directional Backscatter (DBS) Electron 
Detector. All samples were imaged un-coated, in high vacuum 
mode. 100 
3.5. Circular Dichroism 
CD spectra were recorded on a JASCO J-810 spectropolarimeter 
using 1 mm path length cuvettes. The scan speed was 100 
nm/min, and spectra were averaged over 8 scans. All samples 
were tested at 25 °C. The sample concentration was 100 µM in 105 
deionized water. The CD for background reference (water) was 
measured and subtracted from the sample. 
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3.6. Dynamic Light Scattering (DLS) 
Dynamic light scattering and zeta potential experiments were 
conducted on a Malvern Instruments Zetasizer Nano ZS 
(Worcestershire, UK). The machine was calibrated using a 60 nm 
polystyrene standard. Each sample (1 mL, 100 µM) was loaded 5 
into a cell, and the particle size and zeta potential were measured 
simultaneously in triplicate. To determine the size distribution, 1 
mL samples were placed in PCS1115 glass cuvettes and DLS was 
performed at 25 °C at 173° backscatter angle with 120 s 
equilibration time. The intensity-based z-averaged hydrodynamic 10 
diameters reported based on 11 scans. To measure zeta potential 
via electrophoretic mobility, the samples were added to a cuvette 
equipped with copper chip. The measurement was conducted at 
25 °C and 3 cycles were performed (30 data points per cycle). 
DLS and zeta potential were conducted with 100 µM [WR]4 as a 15 
stock solution. 
3.7. Synthesis of Silver Nanoparticles 
A stock solution of silver nitrate was mixed with NaBH4 in the 
presence of cyclic peptides. Typically, 100 uL of 1 mM peptide 
solution was mixed with 100 uL of 2 mM silver nitrate solution at 20 
room temperature. Then 100 µL of 8 mM solution of NaBH4 was 
added into the mixture to yield colloidal silver with a light 
yellowish color. The UV-Vis spectra of the solution were taken 
using SpectraMax M2 fluorescence spectrophotometer 
(Molecular Devices, CA) at different time intervals. 25 
3.8. Enzyme Activity Assay 
The activity of GAPDH enzyme was measured using KDalert 
GAPDH assay kit (Ambion, Austin, Texas). Briefly, 1 µL of 
GAPDH enzyme was mixed with 99 µL PBS (pH 7.0) in an 
eppendorf tube to create control enzyme solution of activity 0.26 30 
U/ml. Same proportion of enzyme was mixed with different 
concentration of peptide solution (100 µM, 500 µM and 1 mM) in 
PBS. Then 10 µL of enzyme solutions from each tube was taken 
in 96 well plates followed by the addition of 90 µL KDalert 
master mix into it using multichannel pippettor. To determine the 35 
activity of the enzyme, fluorescence of the solutions was 
measured (Excitation: 560 nm, Emission: 590 nm). The reduction 
of NAD+ to NADH was continuously monitored on a SpectraMax 
M2 fluorescence spectrophotometer (Molecular Devices, CA) for 
30 min at room temperature. Fluorescence measurements of 40 
NADH production with control enzyme solution and enzyme in 
100 µM and 500 µM peptide solutions were carried out in 
triplicate. For thermal stability study, the fluorescence of the 
solutions was measured for 60 min at 50 ⁰C. 
3.9. Molecular Modeling 45 
Ab initio Hartree Fock molecular orbital calculations were 
performed at the 6-31G basis set. Geometry of monomers was 
completely optimized (all bond lengths, bond angles and dihedral 
angles were allowed to relax without any constraint). 
Intermolecular interaction calculations using supermolecule 50 
approach were utilized to study stacking efficiency and 
interaction with counterions present in the reaction medium. 
Stacking efficiency = Estacked supermolecule – (Emonomer × no. of 
monomers + Ecounterion × no. of counterions). Molecular modeling 
studies without anion were conducted in the presence of a 1-55 
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
membrane bilayer using SPC water model. Simulation was 
performed at 300 K, and NPT ensemble was taken using 
Martyna-Tobias-Klein Barostat method. Molecular dynamics 
simulations were performed by Shaw's Desmond software. 60 
Membrane was set up by system builder module. Then water was 
added. Whole system was subjected to simulated annealing 
followed by molecular dynamics at room temp for 5 ns. 
3.10. Fluorescence Spectroscopy 
The steady-state fluorescence spectra were taken by a 65 
SpectraMax M2 fluorescence spectrophotometer (Molecular 
Devices, CA) in 96 well plate. The fluorescence of tryptophan 
residues in samples were measured using excitation and emission 
wavelength at 280 nm and 360 nm respectively. The 
measurement was performed by excitation and emission slits with 70 
a nominal band pass of 1 nm.  
3.11. ATR-FTIR 
FT-IR of [WR]4 was carried out using Thermo-Nicolet 380 FT-IR 
spectrophotometer using OMNIC software. ATR-FTIR was used 
to collect the spectra of the sample.  75 
4. Conclusions 
In summary, a new class of surfactant-like cyclic peptides was 
reported. Among all the designed peptides, [WR]n (n = 3-5) 
generated self-assembled vesicle-like nanostructures at room 
temperature as shown by TEM, SEM, and/or DLS. A plausible 80 
mechanistic insight of self-assembly of [WR]5 was investigated 
by molecular modeling studies. Modified [WR]5 analogues, such 
as [WMeR]5. [WR(Me)2]5, [WMeR(Me)2]5, and [WdR]5 exhibited 
different morphologies than [WR]5 as shown by TEM. Surfactant-
like cyclic peptide [WR]5 exhibited significant stabilizing effect 85 
for generated silver nanoparticles and GAPDH activity. The data 
suggested that surfactant cyclic peptides, [WR]5 and [WMeR]5, 
could be promising materials for stabilization of silver 
nanoparticles. These studies established a new class of surfactant-
like cyclic peptides that self-assembled into nanostructures and 90 
could have potential application for stabilizing of silver 
nanoparticles and protein biomolecules. 
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